Frequency of K-ras Mutations in Pancreatic Intraductal Neoplasias Associated with Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis: A Meta-Analysis

Löhr, Matthias, Klöppel, Gunter, Maisonneuve, Patrick, Lowenfels, Albert B., Lüttges, Jutta·2005·Neoplasia
DOI 10.1593/neo.04445

Cited by (346)

Items 201–300 of 346

  1. Inflammation-Related Pancreatic Carcinogenesis
    Juanjuan Dai, Mingjie Jiang, Xingpeng Wang, Ling Tian · 2017 · Pancreas
  2. Indikationen zur Pankreasbiopsie
    J. L�hr, G. Kl�ppel · 2005 · Der Pathologe
  3. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study
    PANKRAS II Study Group, Marta Crous‐Bou, Miquel S. Porta, Eva Morales, Tomás López‐Jiménez, Alfredo Carrato, Elisa Puigdomènech, Francisco X. Real · 2008 · Cancer Causes & Control
  4. Intraepitheliale Neoplasien (PanIN) und intraduktale papillär-muzinöse Neoplasien (IPMN) des Pankreas als Vorläufer des Pankreaskarzinoms
    Claudia Ott, Ernst Heinmöller, Andreas K.A. Gaumann, Jürgen Schölmerich, Frank H. Klebl · 2007 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
  5. Epigenetic regulator ARID1A and stem cell transcription factor SOX9 in the maintenance of pancreatic ductal cell differentiation state and development of intraductal papillary mucinous neoplasia (IPMN) and pancreatic ductal adenocarcinoma (PDAC)
    Naipeng Cui, Jinsong Zhang, Huatian Huang, Lingeng Lu · 2018 · Translational Cancer Research
  6. Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer
    Ligia I. Bastea, Xiang Liu, Alicia K. Fleming Martinez, Veethika Pandey, Heike R. Döppler, Brandy H. Edenfield, Murli Krishna, Lizhi Zhang, E. Aubrey Thompson, Paul M. Grandgenett et al. · 2024 · Nature Communications
  7. Pancreatic inflammation and atrophy are not associated with pancreatic cancer concomitant with intraductal papillary mucinous neoplasm
    Yosuke Yagi, Atsuhiro Masuda, Yoh Zen, Hideyuki Shiomi, Hirochika Toyama, Keitaro Sofue, Mamoru Takenaka, Takashi Kobayashi, Takashi Nakagawa, Kodai Yamanaka et al. · 2017 · Pancreatology
  8. Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer
    Mai A. Mansour, Deena S. Lasheen, Hatem Moustafa Gaber, Khaled A. M. Abouzid · 2020 · RSC Advances
  9. Diagnostic value of K‐ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis
    Guoping Cai, Sepi Mahooti, Fredilyn M. Lipata, David C. Chhieng, Pei Hui · 2012 · Cancer Cytopathology
  10. Differential High-Resolution Melting Analysis for the Detection of K-ras Codons 12 and 13 Mutations in Pancreatic Cancer
    Chunyan Zhang, Wei Guo, Jiong Wu, Binbin Song, Chen Zhang, Qian Dai, Baishen Pan, Yuan Ji, Jinghui Guo · 2011 · Pancreas
  11. The Many Faces of Wnt and Pancreatic Ductal Adenocarcinoma Oncogenesis
    Colin D. Weekes, Robert A. Winn · 2011 · Cancers
  12. Pancreatic Cancer Genomes: Toward Molecular Subtyping and Novel Approaches to Diagnosis and Therapy
    Laura DeLong Wood · 2013 · Molecular Diagnosis & Therapy
  13. Molecular Endoscopic Ultrasound for Diagnosis of Pancreatic Cancer
    Barbara Bournet, Adeline Pointreau, Yannick Delpu, Janick Sèlves, Jérôme Torrisani, Louis Buscail, Pierre Cordelier · 2011 · Cancers
  14. Histopathological Features of Patients with Chronic Pancreatitis due to Mutations in the PRSS1 Gene: Evaluation of BRAF and KRAS2 Mutations
    Peter Felderbauer, Ingo Stricker, Jürgen Schnekenburger, Kerem Bulut, Ansgar M. Chromik, Orlin Belyaev, Christophe Müller, Waldemar H. Uhl, Andrea Tannapfel, Wolfgang Ekkehard Schmidt · 2008 · Digestion
  15. A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-control study
    Tianshu Pang, Guoping Ding, Zhengrong Wu, Guixing Jiang, Yifei Yang, Xiaofei Zhang, Liping Cao · 2017 · Scientific Reports
  16. Cell of Origin of Pancreatic cancer
    Chenlei Zheng, Jianing Wang, Junli Wang, Qi Zhang, Tingbo Liang · 2024 · Pancreas
  17. HER family inhibitors in pancreatic cancer: current status and future directions
    David Berz, Thomas J. Miner, Elise M. McCormack, Howard P. Safran · 2007 · Expert Opinion on Therapeutic Targets
  18. New avenues for the treatment of immunotherapy-resistant pancreatic cancer
    Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Mariana Santos Calmon, Gabriel Lima Correa Santos, Gabriel Reis Rocha, Fabrício Freire de Melo · 2024 · World Journal of Gastrointestinal Oncology
  19. Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma
    Yitao Gong, Zhiyao Fan, Guopei Luo, Qiuyi Huang, Yunzhen Qian, He Cheng, Kaizhou Jin, Quanxing Ni, Xianjun Yu, Chen Liu · 2020 · Pancreatology
  20. Analysis of T‐cell receptor repertoire in peripheral blood of patients with pancreatic cancer and other pancreatic diseases
    Hui Wang, Yue Yuan, Chenglin Lu, Siqi Zhou, Yixuan Zhang, Jing Zhao, Chenghu Xu, Jie Yang, Haochen Su, Borui Li et al. · 2021 · Journal of Cellular and Molecular Medicine
  21. Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
    Robert Ferguson, Karen Aughton, Anthony Evans, Victoria E. Shaw, Jane A. Armstrong, Adam Ware, Laura G. Bennett, Eithne Costello, William Greenhalf · 2023 · Current Issues in Molecular Biology
  22. Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail
    Ahmed Elhariri, Ahmed Alhaj, Daniel H. Ahn, Mohamad Bassam Sonbol, Tanios Bekaii‐Saab, Christina Wu, Michael Scott Rutenberg, John Andrew Stauffer, Jason Scott Starr, Umair Majeed et al. · 2023 · World Journal of Clinical Oncology
  23. Erlotinib in Pancreatic Cancer: Are Tumor Cells the (only) Target?
    Nicola Normanno, Antonella De Luca · 2007 · Journal of Clinical Oncology
  24. Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic Ductal Adenocarcinoma
    Sankha Bhattacharya, Tarun Rajpurohit · 2022 · Current Molecular Pharmacology
  25. Progress in Intestinal Homeostasis and Mechanisms of Pancreatic Cancer
    Zia Qi, Peng Qi, Xiansen Jiang, Ping Qi · 2025 · Phenomics
  26. Dinaciclib prolongs survival in the LSL-KrasG12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pancreatic ductal adenocarcinoma.
    Jia Ying Yang, Su Hu, Junjie Shangguan, Aydın Eresen, Yu Li, Quanhong Ma, Vahid Yaghmai, Al B. Benson, Zhuoli Zhang · 2020 · PubMed Central
  27. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
    Marta Cáceres, Rita Quesada, Mar Iglesias, Francisco X. Real, María Villamonte, Jaime Martínez de Villarreal, Mónica Pérez, Anna Andaluz, Xavier Moll, ENRIQUE J. BERJANO et al. · 2020 · Scientific Reports
  28. Significance of pancreatic calcification on preoperative computed tomography of intraductal papillary mucinous neoplasms
    Masahiro Tsujimae, Atsuhiro Masuda, Hideyuki Shiomi, Hirochika Toyama, Keitaro Sofue, Eisuke Ueshima, Kohei Yamakawa, Shigeto Ashina, Yasutaka Yamada, Takeshi Tanaka et al. · 2019 · Journal of Gastroenterology and Hepatology
  29. Genes and Proteins Differentially Expressed during In Vitro Malignant Transformation of Bovine Pancreatic Duct Cells
    Ralf Jesnowski, Dmitri Zubakov, R. Faissner, Jörg Ringel, Jörg D. Hoheisel, Ralf Lösel, Martina Schnölzer, Matthias J. Löhr · 2007 · Neoplasia
  30. Impairment of mitochondrial respiratory function as an early biomarker of apoptosis induced by growth factor removal
    Hélène Lemieux, Patrick Subarsky, Christine Doblander, Martin Wurm, Jakob Troppmair, Erich Gnaiger · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Evolution of structure-guided drug design strategies targeting mutations in codon 12 of KRAS
    Sadaf Dorandish, Komal Bhayekar, Anuradha Singh, Narva Deshwar Kushwaha, Evan Malin, Sara Serafimovski, Jeremy M. Kelm, Navnath S. Gavande, Naga Rajiv Lakkaniga · 2025 · RSC Medicinal Chemistry
  32. Inflammation and de-differentiation in pancreatic carcinogenesis
    Takahiro Seimiya, Motoyuki Otsuka, Takuma Iwata, Eri Tanaka, Tatsunori Suzuki, Kazuma Sekiba, Mari Yamagami, Rei Ishibashi, Kazuhiko Koike · 2018 · World Journal of Clinical Cases
  33. Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma
    Wael Al Zoughbi, Silvia Schauer, Martin Pichler, Gerald Höefler · 2018 · Pathobiology
  34. Precursor Lesions of Pancreatic Cancer
    Hanno Matthaei, Anirban Maitra · 2010 · Springer eBooks
  35. Surveillance and Early Diagnosis of Pancreatic Cancer
    Seungmin Bang · 2015 · The Korean Journal of Pancreas and Biliary Tract
  36. Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study
    Sumaira Qayoom, Apoorva Agarwal, Preeti Agarwal, Akshay Anand, Rashmi Raj, Sameer Gupta, Ajay Kumar Singh · 2023 · Cureus
  37. Cell-Free Tumor DNA Detection-Based Liquid Biopsy of Plasma and Bile in Patients with Various Pancreatic Neoplasms
    Mark S. Jain, David Atayan, Рахматуллин Тагир Ирекович, Tatyana E. Dakhtler, Pavel Popov, Pavel Kim, Mikhail Viborniy, И С Гонтарева, Larisa Mikhailovna Samokhodskaya, V. Egorov · 2024 · Biomedicines
  38. Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
    Timothy Chao, Zixuan Wang, Wilbur Bo Bowne, Clifford J. Yudkoff, Ava Torjani, Vishal Swaminathan, Taylor R. Kavanagh, Austin Roadarmel, Cyrus J. Sholevar, Shawnna Cannaday et al. · 2024 · Archives of Pathology & Laboratory Medicine
  39. KRAS fluorescence in situ hybridisation testing for the detection and diagnosis of pancreatic adenocarcinoma
    Noriyuki Shiroma, Koji Arihiro, Miyo Oda, Makoto Orita · 2018 · Journal of Clinical Pathology
  40. A comprehensive review of mucinous ovarian cancer: insights into epidemiology, risk factors, histological characteristics, and clinical outcomes
    Sumedha Gupta, Dheer Singh Kalwaniya, Saritha Shamsunder · 2024 · International Journal of Reproduction Contraception Obstetrics and Gynecology
  41. Intraductal Papillary Mucinous Neoplasm and Pancreas Divisum: Two Cases
    Joseph A. Baiocco, Colin T. Ackerman, James L. Crawford, Charles J. Yeo · 2016 · Case Reports in Pancreatic Cancer
  42. KRAS Mutation Testing on Endoscopic Ultrasound-Guided Fine-Needle Aspiration Samples Improves the Diagnostic Accuracy of Pancreatic Cancer
    Maximus C.F. Yeung, Tony W.H. Shek · 2022 · Pancreas
  43. K-ras gene mutation analysis to diagnosis pancreatic adenocarcinoma from endoscopic ultrasound-guided tissue acquisition; a systematic review and meta-analysis
    Takashi Tamura, Reiko Ashida, Ke Wan, Toshio Shimokawa, Masayuki Kitano · 2023 · Pancreatology
  44. Performance of K-ras mutation analysis plus endoscopic ultrasoundguided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis
    Ying Xu, Duanmin Hu, Zhu Qi, Yunwei Sun · 2014 · Chinese Medical Journal
  45. Factores de riesgo y diagnóstico temprano del cáncer de páncreas
    Antonio López‐Serrano · 2009 · Gastroenterología y Hepatología
  46. MUTYH Exon 7 and 13 Mutations Associated with Colorectal Cancer (MAP Syndrome) Are Not Commonly Associated with Sporadic Pancreatic Cancer
    Lauren M. Smith, Saima Sharif, Randall E. Brand, Erin N. Fink, Janette Lamb, David Clement Whitcomb · 2009 · Pancreatology
  47. Personalizing Pancreatic Cancer Medicine: What are the Challenges?
    Krissi Danielsson, Daniel Ansari, Roland E. Andersson · 2012 · Personalized Medicine
  48. Pathobiology of pancreatic cancer: implications on therapy
    Ivonne Regel, Simone Hausmann, Simone Benitz, Iréne Esposito, Jorg H. Kleeff · 2015 · Expert Review of Anticancer Therapy
  49. Assay design and optimization of mutant-enriched PCR based method for detection of K-ras gene mutations in pancreatic carcinoma.
    Jana Ugorcakova, Tibor Hlavatý, Pavel Babál, Pavol Janega, Gabriela Bukovská, Nora Halgasova, Anna Hlavatá, Jozef Timko, Ivan Ďuriš · 2006 · PubMed
  50. Prediction of Recurrence With KRAS Mutational Burden Using Ultrasensitive Digital Polymerase Chain Reaction of Radial Resection Margin of Resected Pancreatic Ductal Adenocarcinoma
    Sung Joo Kim, Mi-Ju Kim, Ji-Soo Han, You-Na Sung, Soyeon An, Jae Hoon Lee, Ki Byung Song, Dae Wook Hwang, Sang Soo Lee, HyungJun Cho et al. · 2019 · Pancreas
  51. Cancer of Exocrine Pancreas
    Daniele Fanale, Giorgio Madonia, Antonio Galvano, Marc Peeters, Albert J. ten Tije, Juan Iovanna, Antonio Dello Russo · 2021 · UNIPA Springer series
  52. Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early pre-neoplastic pancreatic lesions
    Eileen S. Carpenter, Ahmed M. Elhossiny, Padma Kadiyala, Jay Li, Jake J. McGue, Brian D. Griffith, Yaqing Zhang, Jacob Edwards, Sarah Nelson, Fatima Lima et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Catching pancreatic cancer early: Are we there yet?
    Aminath Rana Abdul Rasheed, Rhun Yian Koh, Wei-Meng Lim, Chun‐Wai Mai, Chin-King Looi · 2025 · Journal of the National Cancer Center
  54. microRNAs in pancreatic cancer: Key modulators of tumor progression and therapeutic resistance
    Hadi Sadeghi, Moein Kohkalani, Seyyed Amin Seyyed Rezaei, Saba Kargarmonhaser, Faezeh Mahd Gharebagh, Amin Nikdouz, Arezoo Hosseini · 2026 · Biomedicine & Pharmacotherapy
  55. Addition of analysis of KRAS mutation or immunohistochemistry with MUC 1 and carcinoembryonic antigen improves the diagnostic performance of fine needle aspiration cytology for the diagnosis of pancreatic carcinoma
    Catalina Gómez‐Peñaloza, Mónica Lizzette Serrano-Arévalo, Lidia F. Villegas‐González, Lorena Flores‐Hernández, Leonardo Saul Lino-Silva, Erika Ruíz‐García, José Díaz‐Chávez · 2019 · Cytopathology
  56. A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer
    Zhihang Xu, Wenquan Wang, Liang Liu, Wenhui Lou · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  57. The Positive Feedback Loop Between Inflammation and Mutant KRAS Genes Promotes Malignant Transformation in Chronic Pancreatitis
    Fan Yang, Lei Li, Xiangyu Kong · 2022 · Cancer Screening and Prevention
  58. Shining the spotlight on shed kras in pancreatic cancer
    Lorenzo F. Sempere, Murray Korc · 2008 · Cancer Biology & Therapy
  59. A Review of the Past, Present, and Future Directions of Neoplasia
    Alnawaz Rehemtulla, Brian Dale Ross · 2005 · Neoplasia
  60. Complexity of molecular alterations impacts pancreatic cancer prognosis
    Ivonne Regel · 2013 · World Journal of Gastrointestinal Oncology
  61. Mucinous Epithelial Ovarian Cancer
    Marcela G.del Carmen · 2014
  62. Epidemiological studies of the etiology of pancreatic cancer
    Juhua Luo · 2008 · Figshare
  63. Cystic lesions and their role in pancreatic cancer risk stratification
    Rebecca G. Lyons, Stephen G. Maher, Joanne Lysaght · 2026 · Translational Oncology
  64. Pancreatic Cancer
    G. Narayanan, E. M. Ruiz, Thomas Scagnelli, S. van der Lei · 2026 · Springer eBooks
  65. Molecular Signaling Pathways in Pancreatic Cancer
    Genevieve Marie Boland, Sarah P. Thayer · 2008 · Springer eBooks
  66. Les altérations génétiques dans les lésions précancéreuses pancréatiques et leurs implications en clinique
    Olivıer Turrini, Carla Eliana Cano, A. Legoffic, Jean‐Robert Delpéro, Jean–Charles Dagorn, Juan Iovanna · 2009 · Gastroentérologie Clinique et Biologique
  67. Microinvasion of High-Grade Pancreatic Intraepithelial Neoplasia
    Natsuko Kawada, Hiroyuki Uehara, Ryoji Takada, Takuo Yamai, Nobuyasu Fukutake, Kazuhiro Katayama, Akemi Takenaka, Shigenori Nagata, Yasuhiko Tomita · 2013 · Case Reports in Gastroenterology
  68. Analysis of K-ras gene codon 12 mutation in pancreatic tissue of patients with pancreatic cancer
    Aleksandra Nikolić, S Knĕzević, M. Krsmanovic, Marjan T. Micev, Momčilo Ristanović, Dragica P. Radojkovic · 2009 · Archives of Biological Sciences
  69. A Colorimetric Method for Detection of K-ras Codon 12 Point Mutations in DNA Extracted from Tissue and Peripheral Blood in Pancreatic Disorders
    Robert A. Ollar, Avram M. Cooperman, Michael E. Wayne, James F. Barrecchia, Niket Sonpal, Sushil Duddempudi, Franklin Kasmin · 2010 · Biochemical Genetics
  70. Molecular Pathology of Pancreatic Cancer Precursor Lesions
    Lodewijk A.A. Brosens, G. Johan A. Offerhaus · 2013 · Springer eBooks
  71. Pancreatic Carcinogenesis
    Valentin Taucher, Johannes Haybaeck · 2017 · Springer eBooks
  72. Mouse Models of Pancreatic Exocrine Cancer
    Pedro Antonio Pérez-Mancera · 2018 · Springer eBooks
  73. Translational Implications of Molecular Genetics for Early Diagnosis of Pancreatic Cancer
    Michael Anthony Hollingsworth · 2013 · Springer eBooks
  74. The Role of Non-cancerous Cells in Cancer: Pancreatic Ductal Adenocarcinoma as a Model to Understand the Impact of Tumor Microenvironment on Epithelial Carcinogenesis
    Mert Erkan, Tania Brocks, Helmut Friess · 2013 · Springer eBooks
  75. Epidemiology and genetics of pancreatic cancer
    Srinivasa R. Prasad, Rong Zeng · 2008 · Cambridge University Press eBooks
  76. Molecular Relationships Between Chronic Pancreatitis and Cancer
    Craig D. Logsdon, Baoan Ji, Rosa F. Hwang · 2009 · Springer eBooks
  77. Novel Therapeutic Strategies for Pancreatic Cancer
    Bridget A. Quinn · 2014 · VCU Scholars Compass (Virginia Commonwealth University)
  78. Chronic pancreatitis: pancreatic cancer risk factors
    N. B. Gubergrits, N. V. Byelyayeva, А. В. Цыс, T. L. Mozhynа, Г. М. Лукашевич, П. Г. Фоменко · 2020 · Herald of Pancreatic Club
  79. Pancreatic Inflammation and Carcinogenesis
    Constantinos P. Zambirinis and George Miller · 2015
  80. Targeted Drug Therapy in Pancreatic Cancer
    Don Lynn Gibbons, Robert A. Wolff, Gauri A Varadhachary · 2008 · Humana Press eBooks
  81. THE MECHANISM OF TUMORIGENESIS IN THE IMMORTALIZED HUMAN PANCREATIC CELL LINES: CELL CULTURE MODELS OF HUMAN PANCREATIC CANCER
    Zhe Chang · 2011 · Digital Commons-TMC (Texas Medical Center)
  82. Acceleration of the PanIN Development in Mice Expressing Oncogenic K-Ras Due to a High Fat Diet
    Bincy Philip · 2013 · Digital Commons-TMC (Texas Medical Center)
  83. Pathology, genetic alterations, and targets of differentially expressed microRNAs in pancreatic cancer
    Thomas D. Schmittgen, Ana Clara P. Azevedo‐Pouly · 2014 · Gastrointestinal Cancer Targets and Therapy
  84. Brèves de l’AERIO
    F.-G. Riet, C.-H. Canova, L. Feuvret, C. Bourgier · 2013 · ONCOLOGIE
  85. Neoplasia: Where We Have Been and Where We Are Going
    Alnawaz Rehemtulla · 2006 · Neoplasia
  86. Neoplasia: An Anniversary of Progress
    Alnawaz Rehemtulla · 2007 · Neoplasia
  87. Development of pancreatic carcinoma in chronic calcifying pancreatitis (CCP)
    Toyoma Kaku, Tetsuhide Ito, Naoko Inoue, Ken Kawabe, Takamasa Oono, Yoshiyuki Arita · 2005 · Suizo
  88. Identificação de micrornas diferencialmente expressos em células pulmonares e pancreáticas transformadas pelo oncogene KRAS
    Mateus Nóbrega Aoki · 2014 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  89. Influències clíniques i ambientals en la prevalença de mutacions en l'oncogèn K-ras en pacients amb adenocarcinoma ductal de pàncrees
    Marta Crous‐Bou · 2009 · TDX (Tesis Doctorals en Xarxa)
  90. Inhibition of Pancreatitis and Carcinogenesis by Capsaicin
    Wanying Zhang, Jie Liao, Haonan Li, Allison L. Yang, Sanjay Srivastava, Guang‐Yu Yang · 2013 · Springer eBooks
  91. The role of PAK4 in pancreatic cancer
    Helen A. King · 2014
  92. ASSOCIAZIONE TRA STATO MUTAZIONALE DI KRAS E PATTERN DI ESPRESSIONE GENETICA NEL CARCINOMA DEL PANCREAS
    Alessandro Bittoni · 2016 · Università Politecnica delle Marche (Università Politecnica delle Marche)
  93. Current state of the evolving MMMN cancer progression models of cancer
    Sam Thiagalingam · 2015 · Cambridge University Press eBooks
  94. Oncogenic KRAS and the Inflammatory Micro-Environment in Pancreatic Cancer
    Hui-Hua Chang, Andrea Schmidt, Guido Eibl · 2016 · Elsevier eBooks
  95. Prognostic and Predictive Factors for Pancreatic Adenocarcinoma
    Petr Karásek, Markéta Hermanová · 2016 · Klinicka onkologie
  96. Pankreatik duktal adenokarsinomlar ve ampüller bölge adenokarsinomlarında HSF-1 ve P53 ekspresyonlarının prognostik faktörlerle ilişkisi
    Mehmet Zengin, Nevra Dursun, Esra Paşaoğlu, Oğuz Koç · 2017 · Turkish Journal of Clinics and Laboratory
  97. Mouse Models of Pancreatic Exocrine Cancer
    Pedro Antonio Pérez-Mancera · 2017 · Springer eBooks
  98. Expression und Regulation von Krüppel-like-factor-5 (KLF5) in humanen Pankreaskarzinomzellen: ein neues molekulares Target? Expression and regulation of Krüppel-like factor 5 (KLF5) in human pancreatic cancer cells: a new molecular target?
    Christian Moser, Akihiro Mori, Sven Arke Lang, C. Hackl, Hans Jürgen Schlitt, Edward Kenneth Geissler, Oliver Stöltzing · 2009
  99. “Fatal chain”: from acute pancreatitis to pancreatic cancer
    N. B. Gubergrits, Г. М. Лукашевич, П. Г. Фоменко, N. V. Byelyayeva · 2017 · Herald of Pancreatic Club
  100. Molecular Cancer Biology
    Hasan Murshed · 2019 · Elsevier eBooks